Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

A Signpost for Sepsis

MP3 WAV

  • Norbert: Dave, do you know what's responsible for half of all hospital deaths in America?

    Dave: I don't know... heart failure?

    Norbert: No, it's sepsis!

    Dave: Ah... of course! Sepsis is when the body's immune system overreacts to an infection and begins attacking its own organs and tissues. But it's possible scientists have identified the biomarker that can predict who's at risk of dying from sepsis so doctors can intervene earlier.

    Sepsis can be triggered by any kind of an infection, including viruses, bacteria, fungi and parasites. Very early in sepsis, the immune system produces large amounts of various proteins to ramp up the immune response. One is a powerful process called pyroptosis which destroys infected cells. But it also fuels the development of sepsis.

    When scientists looked for genetic variations that made people more susceptible to pyroptosis, they identified a single change in DNA that creates a molecule called methylthioadenosine or MTA. Scientists hypothesized that MTA levels can predict who would die of sepsis, and changing its levels can increase survival.

    Early in infections, its level in the blood goes up, but falls in tissues. But if an infection isn't dealt with, more MTA is released, which indicates an out of control immune system. Indeed, in 62 patients, the chances of dying from sepsis were increased over seven times when MTA levels are doubled. But in their experiments with mice, those treated with MTA before a bacterial infection lived longer. The key is to find out when to raise and lower MTA levels during sepsis to improve survival.

More Information

Researchers Identify Biomarker That Predicts Death in Sepsis Patients
Runaway immune system response to infection has distinct markers

Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis
Sepsis is a deleterious inflammatory response to infection with high mortality. Reliable sepsis biomarkers could improve diagnosis, prognosis, and treatment. Integration of human genetics, patient metabolite and cytokine measurements, and testing in a mouse model demonstrate that the methionine salvage pathway is a regulator of sepsis that can accurately predict prognosis in patients...

Sepsis
Sepsis is the body's extreme response to an infection. It is life-threatening and without timely treatment can rapidly cause tissue damage, organ failure, and death...

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.